Koers ReShape Lifesciences Inc.
Aandelen
RSLS
US76090R2004
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,1852 USD | -12,17% | +11,30% | -25,83% |
15/05 | Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024 | |
01/04 | Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024 |
Omzet 2024 * | 9,99 mln. 9,22 mln. | Omzet 2025 * | 11,99 mln. 11,06 mln. | Marktkapitalisatie | 4,34 mln. 4,01 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -6 mln. -5,53 mln. | Nettowinst (verlies) 2025 * | -5 mln. -4,61 mln. | EV/omzet 2024 * | 0,43 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,36 x |
K/w-verhouding 2024 * |
-0,41
x | K/w-verhouding 2025 * |
-0,51
x | Werknemers | 29 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,83% |
Recentste transcriptie over ReShape Lifesciences Inc.
1 dag | -12,17% | ||
1 week | +11,30% | ||
Lopende maand | +11,57% | ||
1 maand | +12,04% | ||
3 maanden | +11,10% | ||
6 maanden | -10,57% | ||
Lopend jaar | -25,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 01-02-20 |
Director of Finance/CFO | 63 | 15-06-21 | |
Dov Gal
CMP | Compliance Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 01-01-16 |
Dan Gladney
CHM | Chairman | 70 | 01-11-15 |
Director/Board Member | 70 | 15-06-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
21-05-24 | 0,1852 | -12,17% | 1 904 353 |
20-05-24 | 0,2109 | +19,67% | 6 084 055 |
17-05-24 | 0,1762 | +3,40% | 6 375 051 |
16-05-24 | 0,1704 | -2,07% | 487 286 |
15-05-24 | 0,174 | +4,57% | 487 887 |
uitgestelde koers Nasdaq, 21 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-25,83% | 4,34 mln. | |
+11,18% | 225 mld. | |
+15,22% | 197 mld. | |
+19,19% | 143 mld. | |
+30,89% | 111 mld. | |
+2,05% | 64,72 mld. | |
+18,48% | 54,44 mld. | |
+5,12% | 51,06 mld. | |
+10,53% | 45,03 mld. | |
+5,98% | 37,4 mld. |